Results 261 to 270 of about 3,775,993 (302)
Some of the next articles are maybe not open access.
Disease‐modifying antirheumatic drugs
Medicinal Research Reviews, 1985John A. Carlson +3 more
openaire +3 more sources
Cancer epigenetics in clinical practice
Ca-A Cancer Journal for Clinicians, 2023Veronica Davalos, Manel Esteller
exaly
Disease-Modifying Antirheumatic Drugs
20111. Disease-Modifying Antirheumatic Drug (DMARD) Designations in RA a. A drug must change the course of the disease for at least 1 year b. Change evidenced by one of the following i. Sustained improvement in physical function ii. Decreased inflammatory synovitis iii. Slowing or prevention of structural joint damage c.
openaire +2 more sources
[Disease modifying antirheumatic drugs].
Revue medicale suisse, 2014The natural history of rheumatoid arthritis, previously burdened with high morbidity, has been strongly modified by appropriate treatment. Early diagnosis and treatment, and follow-up by a specialist, with the aim to achieve remission or low disease activity, are essential for the functional outcome of patients.
Luong, Ba K, Gabay, C
openaire +2 more sources
Disease‐modifying antirheumatic drugs
Medical Journal of Australia, 1992Malcolm D. Smith +2 more
openaire +3 more sources
The early history of antirheumatic drugs
Arthritis & Rheumatism, 1970Thomas G. Benedek, Gerald P. Rodnan
openaire +3 more sources
Modern developments in germline pharmacogenomics for oncology prescribing
Ca-A Cancer Journal for Clinicians, 2022Natalie M Reizine, Peter H O'donnell
exaly